TARGETING OF LYSYL OXIDASE-LIKE-2 (LOXL2) PROMOTES REVERSAL OF LIVER FIBROSIS VIA INHIBITION OF COLLAGEN CROSS-LINKING AND FIBROTIC MATRIX STABILIZATION

被引：0
|
作者：
Ikenaga, N. [1 ]
Yoshida, S. [1 ]
Liu, S. B. [1 ]
Chung, J. [1 ]
Sverdlov, D. [1 ]
Marshall, D. [2 ]
Smith, V. [2 ]
Kovalenko, M. [2 ]
Karnik, S. [2 ]
Afdhal, N. [1 ]
Popov, Y. [1 ]
机构：
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60598-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
596
引用
收藏
页码：S243 / S244
页数：2
相关论文
共 46 条
  • [1] Targeting lysyl oxidase like 2 (LOXL2) inhibits collagen cross-linking and accelerates reversal of pre-established liver fibrosis
    Ikenaga, Naoki
    Yoshida, Shuhei
    Liu, Susan B.
    Chung, Jeanhee
    Sverdlov, Deanna
    Marshall, Derek
    Barry, Vivian
    Smith, Victoria
    Kovalenko, Maria
    Karnik, Satyajit
    Afdhal, Nezam H.
    Popov, Yury
    HEPATOLOGY, 2013, 58 : 219A - 220A
  • [2] Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin
    Schmelzer, Christian E. H.
    Heinz, Andrea
    Troilo, Helen
    Lockhart-Cairns, Michael P.
    Jowitt, Thomas A.
    Marchand, Marion F.
    Bidault, Laurent
    Bignon, Marine
    Hedtke, Tobias
    Barret, Alain
    McConnell, James C.
    Sherratt, Michael J.
    Germain, Stephane
    Hulmes, David J. S.
    Baldock, Clair
    Muller, Laurent
    FASEB JOURNAL, 2019, 33 (04): : 5468 - 5481
  • [3] Lysyl Oxidase-like-2 (LOXL2) Is a Major Isoform in Chondrocytes and Is Critically Required for Differentiation
    Iftikhar, Mussadiq
    Hurtado, Paola
    Bais, Manish V.
    Wigner, Nate
    Stephens, Danielle N.
    Gerstenfeld, Louis C.
    Trackman, Philip C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (02) : 909 - 918
  • [4] Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC)
    French, Dorothy
    Huntzicker, Erik G.
    Goodman, Zachary D.
    Shea, Patrick R.
    Ding, Dora
    Schall, Raul E. Aguilar
    Smith, Victoria
    Subramanian, Mani
    Levy, Cynthia
    Bowlus, Christopher L.
    Eksteen, Bertus
    Chapman, Roger W.
    Muir, Andrew J.
    Goldstein, David B.
    Myers, Robert P.
    HEPATOLOGY, 2016, 64 : 194A - 194A
  • [5] Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
    Ikenaga, Naoki
    Peng, Zhen-Wei
    Vaid, Kahini A.
    Liu, Susan B.
    Yoshida, Shuhei
    Sverdlov, Deanna Y.
    Mikels-Vigdal, Amanda
    Smith, Victoria
    Schuppan, Detlef
    Popov, Yury V.
    GUT, 2017, 66 (09) : 1697 - 1708
  • [6] LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
    Ma, Hsiao-Yen
    Li, Qingling
    Wong, Weng Ruh
    N'Diaye, Elsa-Noah
    Caplazi, Patrick
    Bender, Hannah
    Huang, Zhiyu
    Arlantico, Alexander
    Jeet, Surinder
    Wong, Aaron
    Emson, Claire
    Brightbill, Hans
    Tam, Lucinda
    Newman, Robert
    Roose-Girma, Merone
    Sandoval, Wendy
    Ding, Ning
    SCIENCE ADVANCES, 2023, 9 (21)
  • [7] NUDT21 regulates lysyl oxidase-like 2(LOXL2) to influence ECM protein cross-linking in silica-induced pulmonary fibrosis
    Peng, Lan
    Sun, Wenqing
    Cheng, Demin
    Jia, Xinying
    Lian, Wenxiu
    Li, Ziwei
    Xiong, Haojie
    Wang, Ting
    Liu, Yi
    Ni, Chunhui
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2025, 290
  • [8] Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy
    Puente, Angela
    Ignacio Fortea, Jose
    Posadas, Miguel
    Garcia Blanco, Agustin
    Rasines, Laura
    Cabezas, Joaquin
    Arias Loste, Maria Teresa
    Llerena, Susana
    Iruzubieta, Paula
    Fabrega, Emilio
    Crespo, Javier
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [9] Anti-lysyl oxidase like-2 (LOXL2) treatment paves the way for macrophage-mediated collagen degradation in liver fibrosis
    Klepfish, Mordehay
    Vugman, Milena
    Varol, Chen
    Sagi, Irit
    HEPATOLOGY, 2016, 64 : 516A - 516A
  • [10] AGE RELATED FIBROSIS IS IMPROVED BY REDUCING COLLAGEN CROSS-LINKING WITH LYSYL OXIDASE INHIBITION
    Rosin, N.
    Sopel, M.
    Falkenham, A.
    Myers, T.
    Lee, T. D.
    Legare, J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S247 - S247
12345